sporadic inclusion body myositis
GPTKB entity
Statements (48)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:disease
inflammatory myopathy |
gptkbp:abbreviation |
sIBM
|
gptkbp:affects |
gptkb:skeletal_muscle
quadriceps pharyngeal muscles finger flexors |
gptkbp:affectsMore |
men
|
gptkbp:associatedWith |
inclusion bodies
endomysial inflammation rimmed vacuoles |
gptkbp:causedBy |
unknown
|
gptkbp:complication |
falls
dysphagia loss of mobility |
gptkbp:diagnosedBy |
electromyography
muscle biopsy blood tests |
gptkbp:differentialDiagnosis |
amyotrophic lateral sclerosis
muscular dystrophy polymyositis |
gptkbp:field |
neurology
rheumatology |
gptkbp:firstDescribed |
1971
|
gptkbp:hasGeneticComponent |
unknown
|
https://www.w3.org/2000/01/rdf-schema#label |
sporadic inclusion body myositis
|
gptkbp:ICD-10_code |
G72.4
|
gptkbp:MeSH_ID |
D020526
|
gptkbp:notResponsiveTo |
immunosuppressive therapy
corticosteroids |
gptkbp:OMIM |
147421
|
gptkbp:onset |
adulthood
|
gptkbp:pathology |
protein aggregates
T-cell infiltration cytoplasmic inclusions |
gptkbp:prevalence |
rare
|
gptkbp:progression |
slowly progressive
|
gptkbp:riskFactor |
male sex
age over 50 |
gptkbp:symptom |
difficulty swallowing
muscle weakness muscle wasting |
gptkbp:treatment |
occupational therapy
physical therapy assistive devices no effective drug therapy |
gptkbp:bfsParent |
gptkb:inclusion_body_myopathy
|
gptkbp:bfsLayer |
7
|